The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin Therapy

NCT06818851 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Henggliflozin
OTHER: Placebo

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]